ArticleHeart rhythm2025

Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study.

Mohammed Shurrab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.